trending Market Intelligence /marketintelligence/en/news-insights/trending/jwaicwzj5outcxx6x1lblq2 content esgSubNav
In This List

Clearside Biomedical chairperson steps down; replacement appointed

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Clearside Biomedical chairperson steps down; replacement appointed

Clearside BioMedical Inc. said Christy Shaffer stepped down from the position of chairperson but will continue to serve as a member of the board.

The company appointed William Humphries as chairman, effective Feb. 26.

Humphries has served as a director of Clearside since January 2012 and serves as executive vice president at Ortho Dermatologics, a division of Valeant Pharmaceuticals International Inc.

The Alpharetta, Ga.-based company also appointed Brion Raymond to the newly created position of chief commercial officer.

Prior to joining Clearside, Raymond managed a consulting firm that led multiple strategy projects for clinical-stage biotechnology companies.